Researcher.Life Logo

Microbiome : Impact Factor & More

eISSN: 2049-2618pISSN: 2049-2618
JournalOpen Access

Aims and Scope of Microbiome

The central purpose of Microbiome is to unite investigators conducting microbiome research in environmental, agricultural, and biomedical arenas. Topics broadly addressing the study of microbial communities, such as, microbial surveys, bioinformatics, meta-omics approaches and community/host interaction modeling will be considered for publication. Through this collection of literature Microbiome hopes to integrate researchers with common scientific objectives across a broad cross-section of sub-disciplines within microbial ecology. Less

Key Metrics

CiteScore
24.5
Eigenfactor
0.01 - 0.05
Impact Factor
15 - 20
Scite Index
0.90 5-Year SI
SJR
Q1Microbiology
SNIP
3.4
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Microbiome

Microbiome Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher BMC
Language English
Frequency Continuous publication
Article Processing ChargesEUR 3690 | USD 4590 | GBP 3190
Publication Time4
Editorial Review ProcessPeer review
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year2013
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 4
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessPeer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC0
OA statementVisit website
View less

Planning to publish in Microbiome ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Microbiome

Comparison of BAFF and type I IFN activity in blood and placenta in SLE and healthy pregnancies.
  • 18 May 2026
  • Lupus science & medicine
Incidence of serious infections, herpes zoster and hepatitis B virus reactivation among patients with SLE: a cohort study using a health claims database in Japan
  • 17 May 2026
  • Lupus Science & Medicine
Anti-CD19 monoclonal antibody for systemic lupus erythematosus and neuromyelitis optica spectrum disorder.
  • 7 May 2026
  • Lupus science & medicine
Impact of an online lupus self-management programme in an established, population-based cohort of adults with diagnosed SLE: a mixed-methods study.
  • 7 May 2026
  • Lupus science & medicine
Reference intervals for aCL and anti-β2GPI IgAGM antibodies in a large health-inspection population: a foundational study for combined-isotype assay interpretation.
  • 7 May 2026
  • Lupus science & medicine
Double humanised lupus mouse model with human immune system and faecal microbiota from patients with SLE.
  • 7 May 2026
  • Lupus science & medicine
Comparison of BAFF and type I IFN activity in blood and placenta in SLE and healthy pregnancies.
  • 18 May 2026
  • Lupus science & medicine
Incidence of serious infections, herpes zoster and hepatitis B virus reactivation among patients with SLE: a cohort study using a health claims database in Japan
  • 17 May 2026
  • Lupus Science & Medicine
Anti-CD19 monoclonal antibody for systemic lupus erythematosus and neuromyelitis optica spectrum disorder.
  • 7 May 2026
  • Lupus science & medicine
Impact of an online lupus self-management programme in an established, population-based cohort of adults with diagnosed SLE: a mixed-methods study.
  • 7 May 2026
  • Lupus science & medicine
Reference intervals for aCL and anti-β2GPI IgAGM antibodies in a large health-inspection population: a foundational study for combined-isotype assay interpretation.
  • 7 May 2026
  • Lupus science & medicine
Double humanised lupus mouse model with human immune system and faecal microbiota from patients with SLE.
  • 7 May 2026
  • Lupus science & medicine

FAQs on Microbiome